Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1

Kornelius Kerl, Natalia Moreno, Till Holsten, Julia Ahlfeld, Julius Mertins, Marc Hotfilder, Marcel Kool, Kerstin Bartelheim, Sabine Schleicher, Rupert Handgretinger, Ulrich Schüller, Michael Meisterernst, Michael C. Frühwald

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

42 Citaten (Scopus)

Samenvatting

Rhabdoid tumors are highly aggressive tumors occurring in infants and very young children. Despite multimodal and intensive therapy prognosis remains poor. Molecular analyses have uncovered several deregulated pathways, among them the CDK4/6-Rb-, the WNT- and the Sonic hedgehog (SHH) pathways. The SHH pathway is activated in rhabdoid tumors by GLI1 overexpression. Here, we demonstrate that arsenic trioxide (ATO) inhibits tumor cell growth of malignant rhabdoid tumors in vitro and in a mouse xenograft model by suppressing Gli1. Our data uncover ATO as a promising therapeutic approach to improve prognosis for rhabdoid tumor patients.

Originele taal-2Engels
Pagina's (van-tot)989-995
Aantal pagina's7
TijdschriftInternational Journal of Cancer
Volume135
Nummer van het tijdschrift4
DOI's
StatusGepubliceerd - 15 aug. 2014
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1'. Samen vormen ze een unieke vingerafdruk.

Citeer dit